UK researchers unveil fake drug test devices

5 November 2001

UK Medicines Control Agency and University of London scientists areworking on near-infrared scanners which they hope will eventually be sufficiently small and cheap to be used in public places to test for counterfeit drugs, reports the Associated Press.

Tony Moffatt, chief scientist at the Royal Pharmaceutical Society of Great Britain, said at the American Association of Pharmaceutical Scientists' convention in Denver, Colorado, USA, that so far, it has been found that the technology can distinguish between the same drugs produced at different plants in Europe. The scanners are similar to other methods which the industry uses to test for fake drugs, he said, adding that, before the machines could be put in public areas, the assistance of the drug industry would be needed in order to develop a database of what their products should contain.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight